2024 annual financial data
Fulcrum Therapeutics 2024 Operating margin
Fulcrum Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -27.37%.
Operating income was -21,897,000 USD and net income was -9,725,000 USD.
Operating cash flow was -2,218,000 USD.
Get free Fulcrum Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 80,000,000 USD
- Operating income
- -21,897,000 USD
- Net income
- -9,725,000 USD
- Operating cash flow
- -2,218,000 USD